0001209191-22-046956.txt : 20220819
0001209191-22-046956.hdr.sgml : 20220819
20220819200009
ACCESSION NUMBER: 0001209191-22-046956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220817
FILED AS OF DATE: 20220819
DATE AS OF CHANGE: 20220819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TREACE JAMES T
CENTRAL INDEX KEY: 0001185191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 221181920
MAIL ADDRESS:
STREET 1: 117 BRISTOL PLACE
CITY: PONTE VEDRA BEACH
STATE: FL
ZIP: 32082
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 471052611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-17
0
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001185191
TREACE JAMES T
203 FORT WADE ROAD
SUITE 150
PONTE VEDRA
FL
32081
1
0
0
0
Common Stock
2022-08-17
4
S
0
15954
19.54
D
1220487
D
Common Stock
2022-08-18
4
S
0
34046
19.09
D
1186441
D
Common Stock
556183
I
By Spouse
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.0200 to $19.9000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.3400 to $19.2950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
2022-08-19